iSERA Lifesciences Limited promoter Dhairyasheel Vasantrao Yadav acquired 4,50,500 equity shares through a preferential allotment on October 1, 2026. This transaction increased his individual stake by 1.83%, though his percentage holding declined to 6.37% due to the significant expansion of the company's total share capital.

The acquisition was executed via a share swap mechanism approved by the board on October 1, 2026. Prior to this specific allotment, Yadav held 11,15,000 shares, representing 13.26% of the voting capital. The new shares were issued as part of a broader preferential allotment that saw the total number of equity shares outstanding rise from 84,08,972 to 2,45,91,772.

Individual Shareholding Changes

The disclosure filed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, details the shift in Yadav's personal ownership structure. While his absolute number of shares increased, the dilution effect of the larger pool of newly issued shares reduced his relative control percentage.

Capital Structure Expansion

The preferential allotment significantly expanded the company's capital base. The total number of equity shares outstanding rose nearly threefold, with each share carrying a face value of ₹10. Consequently, the equity capital increased from ₹8,40,89,720 to ₹24,59,17,720. This structural change affected all shareholders, including other promoter group members such as Pratap Dadasaheb Deshmukh, whose combined holding with Persons Acting in Concert declined to 55.07% from 58.63%.

What the Numbers Show

The data reveals a divergence between absolute and relative holdings for promoter Dhairyasheel Vasantrao Yadav. He added 4,50,500 shares to his portfolio, yet his ownership percentage fell from 13.26% to 6.37%. This indicates that the volume of new shares issued to non-promoter entities or other participants in the swap was disproportionately large compared to Yadav's acquisition. The total share count grew by approximately 161 million shares, while Yadav's holding grew by only 4.5 lakh shares, resulting in substantial dilution despite his active participation in the allotment.

iSERA Lifesciences Limited declared the voting results for its 34th Annual General Meeting (AGM) held on September 29, 2026. Shareholders approved all proposed resolutions, including the adoption of FY26 financial statements and the reappointment of Jitendra Prabhakar Nene as a director.

The meeting was chaired by Jayshree Suresh Jain, Managing Director, and held via video conferencing from the registered office in Pune. A total of 47 members attended the session, which commenced at 3:00 pm and concluded at 3:20 pm. The company facilitated remote e-voting pursuant to Section 108 of the Companies Act, 2013, with the voting window opening on September 26, 2026, at 9:00 am and closing on September 28, 2026, at 5:00 pm.

Key resolutions passed

The shareholders approved the following ordinary business items through e-voting:

1. Adoption of the audited balance sheet, statement of profit and loss, and cash flow statement for FY26, along with the Board's Report and Statutory Auditor's Report.
2. Re-appointment of Jitendra Prabhakar Nene (DIN: 06814833) as a director liable to retire by rotation.

Both items were passed by ordinary resolution with a requisite majority. The Chairman provided an overview of the company's performance and future outlook, allowing members to seek clarifications on agenda items.

Voting process details

Anuj Gupta, a Company Secretary in whole-time practice, served as the scrutinizer for the e-voting process. The facility was managed by MUFG Intime India Private Limited in compliance with Regulation 44 of the SEBI (LODR) Regulations, 2015. During the AGM, members who had not voted remotely were permitted to cast their votes electronically until 15 minutes after the meeting's conclusion.

Voting results summary

The consolidated results of remote e-voting and e-voting at the AGM confirmed that both resolutions were passed unanimously among those who voted. No votes were recorded against either resolution.

The total number of valid votes cast was 781,837, representing approximately 9.3% of the total outstanding shares. Promoters and promoter group did not cast any votes during the remote e-voting or at the AGM. All votes were cast by public non-institutional shareholders.